Yuchen Han
Lawyers
Filters
Magenta Therapeutics $69 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $69 million follow-on offering of common stock of Magenta Therapeutics…
Amerant Bancorp $60 million notes offering
Davis Polk advised the sole book-running manager in an SEC-registered offering by Amerant Bancorp Inc. of $60 million aggregate principal amount of 5.750% notes due 2025. The notes are…
Ralph Lauren $1.25 billion notes offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered offering by Ralph Lauren Corporation of $500 million aggregate…
ADC Therapeutics $267 million IPO
Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which included the exercise in full by the underwriters of their option to…
IDEX $500 million notes offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by IDEX Corporation of $500 million…
Huntington Ingalls Industries $1 billion senior notes offering
Davis Polk advised the representatives of the several initial purchasers, in a Rule 144A/Regulation S offering by Huntington Ingalls Industries, Inc. of $500 million aggregate…
GFL Environmental $2.2 billion dual-listed U.S. and Canadian IPO
Davis Polk advised the underwriters, in connection with a $2.2 billion dual-listed U.S. and Canadian initial public offering of 75,000,000 subordinate voting shares ($1.425 billion)…
Black Diamond Therapeutics $231.3 million IPO
Davis Polk advised the joint book-running managers in connection with an initial public offering of 10,586,316 shares of common stock of Black Diamond Therapeutics, Inc. In addition,…